Until recently, Medicinal 91AV has mostly focused on the exploration of biologically active molecules and their optimization towards pharmaceutical applications. There is, however, an increasing need for medicinal chemists to contribute to the drug discovery and development process more broadly, in order to enable the development of truly improved medicines. This includes providing tools for therapeutic target identification and validation, to explore therapeutic and pathological mechanisms, or even support clinical trials.
This symposium, jointly organised by the Société de Chimie Thérapeutique (SCT) and the Division of Medicinal 91AV & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS), will discuss significant advances that are part of the expanding scope of Medicinal 91AV. A panel of experts will highlight these developments in the areas of chemical biology, metabolite pattern optimization, structural biology, analytics and clinical imaging tracers with specific examples.
This symposium, jointly organised by the Société de Chimie Thérapeutique (SCT) and the Division of Medicinal 91AV & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS), will discuss significant advances that are part of the expanding scope of Medicinal 91AV. A panel of experts will highlight these developments in the areas of chemical biology, metabolite pattern optimization, structural biology, analytics and clinical imaging tracers with specific examples.
